| Financial Year |
March 31 2023 |
| Monetary Funds |
503,222,554.51 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
2,045,042.06 |
| Accounts Receivable |
150,245,694.04 |
| Advances to Suppliers |
3,914,829.53 |
| Other Receivables |
11,198,459.25 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
211,549,880.93 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,243,877.78 |
| Total Current Assets |
885,420,338.10 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
388,882,649.20 |
| Under-construction Projects |
22,074,777.51 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
96,785,854.49 |
| R&D expenses |
-- |
| Goodwill |
68,864,682.85 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
3,804,104.21 |
| Other Non-Current Assets |
97,834,177.77 |
| Sub-Total of Non-Current Assets |
691,465,202.06 |
| Total Assets |
1,576,885,540.16 |
| Short-Term Loans |
10,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
68,754,735.89 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
8,391,154.23 |
| Taxes Payable |
10,411,231.66 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
111,492.10 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
23,929,051.56 |
| Other Current Liabilities |
226,003.98 |
| Sub-Total of Current Liabilities |
123,562,161.59 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,740,001.77 |
| Other Non-Current Liabilities |
15,686,000.00 |
| Sub-Total of Non-Current Liabilities |
35,526,925.45 |
| Total Liabilities |
159,089,087.04 |
| Paid-In Capital(Or Share Stock) |
260,000,000.00 |
| Capital Surplus |
614,555,447.84 |
| Surplus Reserve |
42,488,846.95 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
500,752,158.33 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,417,796,453.12 |
| Owner's Equity（Stockholder's Equity） |
1,417,796,453.12 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,576,885,540.16 |
